This document describes clinical trials of a new treatment for HIV/AIDS. Over 10 months, mice were treated and their HIV infection levels and CD4 counts were measured at regular intervals. For Sample A, HIV infection levels decreased from 97% to 47% while CD4 counts increased from over 80 to over 310. For Sample B, HIV levels stabilized at 78% while CD4 counts increased from over 80 to over 91. The document calls for support to test the drug on humans and make it available globally to improve treatment of HIV/AIDS.